Contribution of the innate immune system to autoimmune myocarditis: A role for complement

Nature Immunology

Volumn 2, Issue 8, 2001, Pages 739-745

  Kaya, Ziya ^a   Afanasyeva, Marina ^a,b   Wang, Yan ^a   Dohmen, K Malte ^a   Schlichting, Jens ^a   Tretter, Theresa ^a   Fairweather, DeLisa ^a,b   Holers, V Michael ^c   Rose, Noel R ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR TYPE 2; CYTOKINE; HERMES ANTIGEN; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ADULTHOOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL MODEL; FEMALE; HEART DILATATION; HEART DISEASE; HEART FAILURE; IMMUNE RESPONSE; IMMUNE SYSTEM; INCIDENCE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANIMALS; AUTOIMMUNITY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MYOCARDITIS; RECEPTORS, COMPLEMENT; T-LYMPHOCYTES;

EID: 0034891226     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/90686     Document Type: Article

References (50)

1. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex
2. The role of complement and complement receptors in induction and regulation of immunity
3. Monoclonal antibodies to mouse complement receptor type I (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative
4. Suppression of the immune response by a soluble complement receptor of B lymphocytes
5. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
6. C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
7. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response
8. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses
9. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice
10. Cardiac myosin induces myocarditis in genetically predisposed mice
11. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis
12. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms
13. + T helper cell and IL-2 independent in BALB/c mice
14. Myosin-induced acute myocarditis is a T cell-mediated disease
15. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis
16. Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity
17. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice
18. Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naive mice
19. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma
20. A single gene controlling hemolytic complement and a serum antigen in the mouse
21. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis
22. Complement deficiency and disease
23. Complement deficiencies
24. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease
25. Autoimmunity in heart disease: Mechanisms and genetic susceptibility
26. Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes
27. Experimental autoimmune myocarditis in A/J mice is an IL-4 dependent disease with a Th2 phenotype
28. Interleukin I or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice
29. Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis
30. Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin
31. Viral myocarditis leading to cardiomyopathy: Do cytokines contribute to pathogenesis?
32. Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis
33. Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis
34. Influence of cytokines and immunosuppressive drugs on major histocompatibility complex class I/II expression by human cardiac myocytes in vitro
35. CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes
36. Dependence of germinal center B cells on expression of CD21/CD35 for survival
37. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors
38. Phagocytosis by human monocyte-derived macrophages. Independent function of receptors for C3b (CR1) and iC3b (CR3)
39. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells
40. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL
41. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes
42. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus
43. B cells of HIV-I-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells
44. Detachment of human immunodeficiency virus type I from germinal centers by blocking complement receptor type 2
45. Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-γ and IL-1
46. C3 production of cultured human epidermal keratinocytes is enhanced by IFNγ and TNFα through different pathways
47. Purification of cardiac myosin. Application to hypertrophied myocardium
48. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor
49. Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors
50. Nasal administration of cardiac myosin suppresses autoimmune myocarditis in mice